News
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Labormed Divests Portfolio of OTC Products to Recordati
London, United Kingdom — Plexus Ventures announces the successful completion of a divestment managed on behalf of Labormed, the largest independent pharmaceutical in Romania. The company divested a package of Rx and OTC products to Recordati of Italy.
AstraZeneca Divests Antimalarials to Alliance Pharmaceuticals; Plexus Ventures Assisted AstraZeneca with this Transaction
London, United Kingdom — Plexus Ventures is pleased to announce the successful completion of a divestment project. Plexus provided transaction services to AstraZeneca UK Limited in the divesture of three of the company's antimalarial brands — PaludrineTM, AvloclorTM...
Events
BIO International Convention - Boston
June 16 – 19, 2025
Click to Schedule a Meeting
CHPI - Frankfurt
October 28 – 30, 2025
Click to Schedule a Meeting
Articles
Nucleic acid delivery: Are you developing what Big Pharma seeks?
Apr 11, 2023
How can we help you?
Plexus Ventures assists with M&A, divestments, licensing, strategic advice and consulting.
Subscribe to
Plexus News
Follow Us
Check out Plexus Ventures and other industry news shared daily.